AGP Executive Report
Last update: 15 minutes agoCannabis Use Disorder Study: A new JAMA Psychiatry analysis of 186,823 U.S. adults (2021–2024) found cannabis use disorder rising as use grows, with CUD increasing from 7.3% to 9.3% in men and 4.5% to 5.6% in women, and moderate-to-severe cases also climbing. DEA/FDA Rescheduling Fallout: DEA materials highlighted inaccurate THC labeling and weak control, while a separate DEA rescheduling hearing transcript is being corrected ahead of public posting. Texas Hemp Legal Fight: Hemp retailers, including San Antonio’s Kingpin Kush, sued Texas over a near-total THC ban, arguing DSHS overstepped the 2018 Farm Bill and harmed jobs and sales. State Policy Shifts: Iowa filed rules to remove the medical program residency requirement for out-of-state patients (with provider certification) and adjust veteran fees; Illinois proposed allowing outdoor cultivation for extraction-only flower. Industry Moves: Vireo Growth completed its acquisition of C21 Investments, expanding its cannabis platform footprint. Business/Branding: Splash Beverage Group rebranded as Endovia Health Sciences, starting trading as EDVA.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
